NCT00607984 Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors Status UNKNOWN Phase NA
NCT00514267 An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00495144 A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00446446 PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) Status COMPLETED Phase PHASE2
NCT00437437 A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664) Status COMPLETED Phase PHASE1
NCT00435669 A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664) Status COMPLETED Phase PHASE1
NCT00422682 A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00421044 A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function Status COMPLETED Phase PHASE1
NCT00420524 A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function Status COMPLETED Phase PHASE1
NCT00412997 LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma Status COMPLETED Phase PHASE1
NCT00412789 Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan Status COMPLETED Phase PHASE1
NCT00410696 Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy Status COMPLETED Phase PHASE2
NCT00402415 Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard Therapy Status TERMINATED Phase PHASE1
NCT00400023 A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00398814 Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers Status COMPLETED Phase PHASE1
NCT00397046 A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00395434 Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1